LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Normalized Growth Rate Inhibition Value Standard Error of the Mean for Normalized Growth Rate Inhibition Value
MCF7 Radicicol
3.33
uM
LJP6
0.3431 0.0236 0.1035 0.0132
MCF7 Radicicol
10
uM
LJP5
0.2315 0.0064 -0.0803 0.0241
MCF7 Radicicol
10
uM
LJP6
0.2321 0.0040 -0.1121 0.0242
MCF7 Withaferin A
0.04
uM
LJP5
1.0267 0.0356 1.0291 0.0393
MCF7 Withaferin A
0.04
uM
LJP6
1.0035 0.0247 1.0009 0.0277
MCF7 Withaferin A
0.12
uM
LJP5
0.9552 0.0450 0.9530 0.0493
MCF7 Withaferin A
0.12
uM
LJP6
0.8824 0.0377 0.8607 0.0483
MCF7 Withaferin A
0.37
uM
LJP5
0.4448 0.0242 0.2969 0.0634
MCF7 Withaferin A
0.37
uM
LJP6
0.4423 0.0168 0.2688 0.0511
MCF7 Withaferin A
1.11
uM
LJP5
0.3298 0.0200 0.1098 0.0211
MCF7 Withaferin A
1.11
uM
LJP6
0.3228 0.0074 0.0667 0.0162
MCF7 Withaferin A
3.33
uM
LJP5
0.1814 0.0340 -0.1995 0.0861
MCF7 Withaferin A
3.33
uM
LJP6
0.1982 0.0336 -0.1921 0.0809
MCF7 Withaferin A
10
uM
LJP5
0.2132 0.0243 -0.1227 0.0573
MCF7 Withaferin A
10
uM
LJP6
0.2123 0.0257 -0.1584 0.0675
SK-BR-3 Seliciclib
0.04
uM
LJP5
1.0292 0.0378 1.0436 0.0539
SK-BR-3 Seliciclib
0.12
uM
LJP5
1.0266 0.0181 1.0411 0.0257
SK-BR-3 Seliciclib
0.37
uM
LJP5
0.9839 0.0359 0.9793 0.0491
SK-BR-3 Seliciclib
1.11
uM
LJP5
0.8990 0.0198 0.8522 0.0246
SK-BR-3 Seliciclib
3.33
uM
LJP5
0.7857 0.0193 0.6774 0.0131
SK-BR-3 Seliciclib
10
uM
LJP5
0.4714 0.0484 0.1464 0.1021
SK-BR-3 AT-7519
0.04
uM
LJP6
0.8063 0.1043 0.7174 0.1376
SK-BR-3 AT-7519
0.12
uM
LJP6
0.4778 0.0707 0.1403 0.0626
SK-BR-3 AT-7519
0.37
uM
LJP6
0.3511 0.0348 -0.1037 0.0430
SK-BR-3 AT-7519
1.11
uM
LJP6
0.2620 0.0279 -0.2840 0.0893